DTC

HOME
ABOUT
- VISION SCIENCE RESEARCH
DRC
- Department of Research Collaboration
DTC
- Department of Technology Commercialization
RESEARCHERS
- Our Co-Researchers
CONTACT

DTC / Technology Commercialization/Medicine

Technology Commercialization

Medicine Engineering Computer Science Material Agriculture Pharmacology Energy Geology Physics Chemistry Biology Food Science

Last update：22 Apr 2022

MICROVESICLE MEMBRANE PROTEIN AND APPLICATION THEREOF

Microvesicles play essential roles in disease progression. The present invention provides a microvesicle membrane protein and application thereof. Disclosed is method comprises phosphorylated CSElL (cellular apoptosis susceptibility protein or CSElL-binding agents for microvesicle isolation, analysis, or binding for disease diagnosis or treatment.

Differential expression of serum GBP-28, NBP-Cyc 3 and TIMP-1 complicates pregnancy in hypertensive disorder pregnancy.

The current study is aimed at analyzing the correlation and differential expression of three entities namely, TIMP metallopeptidase inhibitor-1 (TIMP-1), a glycoprotein, serum adipokine (GBP-28), an amino acid protein and neuroendocrine basic polypeptide NBP-cystatin3 (NBP-Cyc 3) in HDP (Hypertensive Disorders complicating Pregnancy).

Bioinformatics approach to understand the mode of microbial pathogenesis of Chlamydia trachomatis and their implications in gynecologic malignancy.

The current study reports a wide range of C. trachomatis proteins that target the cellular as well as sub-cellular components of the host in gynecologic malignancy.

Modulation of host immune status by Cryptococcus co-infection during HIV-1 pathogenesis and its impact on CD+4 cell and cytokines environment

Cryptococcus infection is the second most common opportunistic infection in HIV patients with an increased rate of morbidity and mortality. Altered immune system during HIV- Cryptococcus co-infection is yet to be explored by laboratory. This study evaluates pro- and the anti-inflammatory cytokines in HIV patients with Cryptococcus co-infection and correlate them with CD4+T cell counts as well as viral loads before the initiation of drug therapy.

Targeted magnetic hyperthermia for extensive cancer treatment

Heating Nanoparticles to Kill Cancer Cells: The magnetic hyperthermia inject the magnetic nanoparticles into the tumor with a syringe, and then expose the particles with an alternating magnetic field (AMF) to heat them.

Targeted contrast agent for imaging-guided surgery for extensive cancer treatments

By injecting a contrast agent and illuminating with near-infrared light, cancer cells will show a fluorescent reaction, help to clearly distinguish normal cells and cancer cells, facilitate surgery, and remove tumor clearly.

Reagent for Monitoring Cancer Therapy Resistance in Real-Time and Extensive Cancer Screening (Tumor Signal-Liquid Biopsy)

Therapy resistances in cancer are often undetectable or detected too late by current methods (CT scan & liquid biopsy), cause patient death and huge expenses in the medical and economic systems! The tumor signal transduction oncoproteins insides tumor cells control tumor survival. With the world‘s first invention “Tumor Signal-Liquid Biopsy” (to assay the tumor signal transduction activity in blood from cancer patients), our product (DxSure) monitors the therapy resistances of all cancer types and all therapy methods in real-time. Our product can help cancer patients get correct drug in time.

VISION SCIENCE RESEARCH SDN BHD, which is short for VSR, is a mature international academic exchange platform jointly established by worldwide universities, research institutes and enterprises in Malaysia.